The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 22, 2026
Filed:
Mar. 26, 2021
Tenvie Therapeutics, Inc., Brisbane, CA (US);
Yusuke Inagaki, Tokyo, JP;
Takashi Kamikubo, Tokyo, JP;
Takahiro Nigawara, Tokyo, JP;
Junko Maeda, Tokyo, JP;
Susumu Yamaki, Tokyo, JP;
Ikumi Kuriwaki, Tokyo, JP;
Maiko Iida, Tokyo, JP;
Junichi Shishikura, Tokyo, JP;
Yuka Koizumi, Tokyo, JP;
Kenji Negoro, Tokyo, JP;
Takanori Koike, Tokyo, JP;
Kengo Saba, Tokyo, JP;
Tenvie Therapeutics, Inc., Brisbane, CA (US);
Abstract
The object of the present invention is to provide a pharmaceutical composition, in particular, a compound suitable for prevention and/or treatment of an inflammatory disease and/or a neurodegenerative disease. The present inventors have extensively conducted studies for discovering a compound having an inhibitory action on NLRP3 inflammasome activation, and found that substituted pyridazine compound has an inhibitory action on NLRP3 inflammasome activation. In this way, the present invention has been attained. The substituted pyridazine compound of the present invention is expected to serve as a prophylactic and/or therapeutic drug for an inflammatory disease and/or a neurodegenerative disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile